Premium
Systemic insecticides used in dogs: potential candidates for phlebotomine vector control?
Author(s) -
Gomez Sonia Ares,
Picado Albert
Publication year - 2017
Publication title -
tropical medicine and international health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 114
eISSN - 1365-3156
pISSN - 1360-2276
DOI - 10.1111/tmi.12870
Subject(s) - vector (molecular biology) , vector control , biology , virology , medicine , veterinary medicine , engineering , recombinant dna , biochemistry , gene , electrical engineering , voltage , induction motor
Summary Zoonotic visceral leishmaniasis ( ZVL ) is a public health problem endemic in some countries. Current control measures, in particular culling infected dogs, have not reduced ZVL incidence in humans. We evaluated the use of five systemic insecticides (spinosad, fluralaner, afoxolaner, sarolaner and moxidectin) currently used in dogs for other purposes (e.g. tick, flea control) in controlling ZVL transmission. The anti‐phlebotomine capacity of these compounds confirmed in experimental studies makes their use in ZVL control programmes very promising. Limitations and benefits of using this new control tool are compared to current practices.